Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1283

1.

Population Pharmacokinetics of Glecaprevir/Pibrentasvir in HCV-infected Japanese Subjects in Phase 3 CERTAIN-1 and CERTAIN-2 Trials.

Suleiman AA, Lin CW, Liu W, Eckert D, Mensing S, Burroughs M, Kato K, Chayama K, Kumada H, Oberoi RK.

J Clin Pharmacol. 2019 Sep 12. doi: 10.1002/jcph.1524. [Epub ahead of print]

PMID:
31515816
2.

Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis.

Namba M, Hiramatsu A, Aikata H, Kodama K, Uchikawa S, Ohya K, Morio K, Fujino H, Nakahara T, Murakami E, Yamauchi M, Kawaoka T, Tsuge M, Imamura M, Chayama K.

J Gastroenterol. 2019 Sep 4. doi: 10.1007/s00535-019-01623-4. [Epub ahead of print]

PMID:
31485782
3.

Real-world learning curve analysis of colorectal endoscopic submucosal dissection: a large multicenter study.

Boda K, Oka S, Tanaka S, Nagata S, Kunihiro M, Kuwai T, Hiraga Y, Furudoi A, Nakadoi K, Okanobu H, Miwata T, Okamoto S, Chayama K.

Surg Endosc. 2019 Sep 3. doi: 10.1007/s00464-019-07104-2. [Epub ahead of print]

PMID:
31482350
4.

Clinical Usefulness of Dual Red Imaging in Gastric Endoscopic Submucosal Dissection: A Pilot Study.

Yorita N, Oka S, Tanaka S, Kotachi T, Nagasaki N, Hata K, Kuroki K, Masuda K, Kurihara M, Kiso M, Boda T, Ito M, Chayama K.

Clin Endosc. 2019 Sep 3. doi: 10.5946/ce.2019.065. [Epub ahead of print]

5.

Successful retreatment with 12 weeks of glecaprevir and pibrentasvir for a genotype 2a HCV-infected hemodialysis patient who failed to respond to 8 weeks of prior glecaprevir and pibrentasvir therapy.

Ohya K, Imamura M, Osawa M, Teraoka Y, Morio K, Fujino H, Ono A, Nakahara T, Murakami E, Yamauchi M, Kawaoka T, Hiramatsu A, Tsuge M, Aikata H, Hayes CN, Chayama K.

Clin J Gastroenterol. 2019 Aug 28. doi: 10.1007/s12328-019-01039-w. [Epub ahead of print]

PMID:
31463795
6.

Regression of idiopathic thrombocytopenic purpura in a patient with eradication of hepatitis C virus by direct-acting antivirals.

Johira Y, Hatooka H, Mori N, Fukuhara T, Takaki S, Shimomura Y, Imamura M, Nelson Hayes C, Tsuji K, Chayama K.

Hepatology. 2019 Aug 20. doi: 10.1002/hep.30900. [Epub ahead of print]

PMID:
31432523
7.

Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy.

Ohya K, Kawaoka T, Namba M, Uchikawa S, Kodama K, Morio K, Nakahara T, Murakami E, Hiramatsu A, Tsuge M, Yamauchi M, Imamura M, Chayama K, Aikata H.

Sci Rep. 2019 Aug 20;9(1):12101. doi: 10.1038/s41598-019-48045-z.

8.

Alcohol Use Disorders Identification Test-consumption Predicts the Risk of Excessive Alcohol Consumption After Liver Transplantation.

Yano T, Ohira M, Sakamoto R, Narisada A, Shimizu S, Tahara H, Ide K, Kobayashi T, Imamura M, Machino A, Yamawaki S, Chayama K, Ohdan H.

Transplant Proc. 2019 Jul - Aug;51(6):1934-1938. doi: 10.1016/j.transproceed.2019.02.031.

PMID:
31399178
9.

Management of HCV patients in cases of direct-acting antiviral failure.

Hayes CN, Imamura M, Chayama K.

Expert Rev Gastroenterol Hepatol. 2019 Sep;13(9):839-848. doi: 10.1080/17474124.2019.1651642. Epub 2019 Aug 8.

PMID:
31392907
10.

Sleep debt: the impact of weekday sleep deprivation on cardiovascular health in older women.

Cabeza de Baca T, Chayama KL, Redline S, Slopen N, Matsushita F, Prather AA, Williams DR, Buring JE, Zaslavsky AM, Albert MA.

Sleep. 2019 Jul 30. pii: zsz149. doi: 10.1093/sleep/zsz149. [Epub ahead of print]

PMID:
31361895
11.

Association of extremely high levels of high-density lipoprotein cholesterol with endothelial dysfunction in men.

Takaeko Y, Matsui S, Kajikawa M, Maruhashi T, Kishimoto S, Hashimoto H, Kihara Y, Hida E, Chayama K, Goto C, Aibara Y, Yusoff FM, Noma K, Nakashima A, Higashi Y.

J Clin Lipidol. 2019 Jul - Aug;13(4):664-672.e1. doi: 10.1016/j.jacl.2019.06.004. Epub 2019 Jun 20.

12.

Effect of Saxagliptin on Endothelial Function in Patients with Type 2 Diabetes: A Prospective Multicenter Study.

Kajikawa M, Maruhashi T, Hidaka T, Matsui S, Hashimoto H, Takaeko Y, Nakano Y, Kurisu S, Kihara Y, Yusoff FM, Kishimoto S, Chayama K, Goto C, Noma K, Nakashima A, Hiro T, Hirayama A, Shiina K, Tomiyama H, Yagi S, Amano R, Yamada H, Sata M, Higashi Y.

Sci Rep. 2019 Jul 15;9(1):10206. doi: 10.1038/s41598-019-46726-3.

13.

Genomic characterization of early-stage esophageal squamous cell carcinoma in a Japanese population.

Urabe Y, Kagemoto K, Hayes CN, Nakamura K, Masuda K, Ono A, Tanaka S, Arihiro K, Chayama K.

Oncotarget. 2019 Jun 25;10(41):4139-4148. doi: 10.18632/oncotarget.27014. eCollection 2019 Jun 25.

14.

Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib.

Kodama K, Kawaoka T, Namba M, Uchikawa S, Ohya K, Morio K, Nakahara T, Murakami E, Yamauchi M, Hiramatsu A, Imamura M, Chayama K, Aikata H.

Oncology. 2019;97(2):75-81. doi: 10.1159/000499715. Epub 2019 Jun 26.

PMID:
31242488
15.

Helicobacter suis infection is associated with nodular gastritis-like appearance of gastric mucosa-associated lymphoid tissue lymphoma.

Takigawa H, Masaki S, Naito T, Yuge R, Urabe Y, Tanaka S, Sentani K, Matsuo T, Matsuo K, Chayama K, Kitadai Y.

Cancer Med. 2019 Aug;8(9):4370-4379. doi: 10.1002/cam4.2314. Epub 2019 Jun 18.

16.

Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice.

Osawa M, Uchida T, Imamura M, Teraoka Y, Fujino H, Nakahara T, Ono A, Murakami E, Kawaoka T, Miki D, Tsuge M, Hiramatsu A, Abe-Chayama H, Hayes CN, Makokha GN, Aikata H, Ishida Y, Tateno C, Miyayama Y, Hijikata M, Chayama K.

J Gen Virol. 2019 Jul;100(7):1123-1131. doi: 10.1099/jgv.0.001268. Epub 2019 Jun 14.

PMID:
31199224
17.

Experience with Balloon Dilatation in Crohn's and Non-Crohn's Benign Small-Bowel Strictures: Is There a Difference?

Tsuboi A, Oka S, Tanaka S, Iio S, Otani I, Kunihara S, Hayashi R, Chayama K.

Gastroenterol Res Pract. 2019 May 6;2019:1262595. doi: 10.1155/2019/1262595. eCollection 2019.

18.

Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradiation therapy.

Masuda K, Urabe Y, Ito M, Ono A, Clair Nelson H, Nakamura K, Kotachi T, Boda T, Tanaka S, Chayama K.

J Gastroenterol. 2019 Jun 13. doi: 10.1007/s00535-019-01596-4. [Epub ahead of print]

PMID:
31197475
19.

Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBP.

Makokha GN, Abe-Chayama H, Chowdhury S, Hayes CN, Tsuge M, Yoshima T, Ishida Y, Zhang Y, Uchida T, Tateno C, Akiyama R, Chayama K.

Sci Rep. 2019 Jun 11;9(1):8462. doi: 10.1038/s41598-019-44934-5.

20.

Hepatitis B virus X protein (HBx) enhances centrosomal P4.1-associated protein (CPAP) expression to promote hepatocarcinogenesis.

Yen CJ, Yang ST, Chen RY, Huang W, Chayama K, Lee MH, Yang SJ, Lai HS, Yen HY, Hsiao YW, Wang JM, Lin YJ, Hung LY.

J Biomed Sci. 2019 Jun 6;26(1):44. doi: 10.1186/s12929-019-0534-9.

21.

Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes.

Xue R, Chen L, Zhang C, Fujita M, Li R, Yan SM, Ong CK, Liao X, Gao Q, Sasagawa S, Li Y, Wang J, Guo H, Huang QT, Zhong Q, Tan J, Qi L, Gong W, Hong Z, Li M, Zhao J, Peng T, Lu Y, Lim KHT, Boot A, Ono A, Chayama K, Zhang Z, Rozen SG, Teh BT, Wang XW, Nakagawa H, Zeng MS, Bai F, Zhang N.

Cancer Cell. 2019 Jun 10;35(6):932-947.e8. doi: 10.1016/j.ccell.2019.04.007. Epub 2019 May 23.

PMID:
31130341
22.

Preceding endoscopic submucosal dissection for T1 colorectal carcinoma does not affect the prognosis of patients who underwent additional surgery: a large multicenter propensity score-matched analysis.

Yamashita K, Oka S, Tanaka S, Nagata S, Hiraga Y, Kuwai T, Furudoi A, Tamura T, Kunihiro M, Okanobu H, Nakadoi K, Kanao H, Higashiyama M, Kuraoka K, Shimamoto F, Chayama K.

J Gastroenterol. 2019 May 18. doi: 10.1007/s00535-019-01590-w. [Epub ahead of print]

PMID:
31104172
23.

Relationships Between Calcium Channel Blockers and Vascular Function Tests.

Maruhashi T, Kajikawa M, Kishimoto S, Matsui S, Hashimoto H, Takaeko Y, Aibara Y, Yusoff FM, Hidaka T, Chayama K, Noma K, Nakashima A, Goto C, Kihara Y, Higashi Y.

Am J Hypertens. 2019 Jun 11;32(7):640-648. doi: 10.1093/ajh/hpz061.

PMID:
31089726
24.

Potential of Helicobacter pylori-uninfected signet ring cell carcinoma to invade the submucosal layer.

Yorita N, Ito M, Boda T, Kotachi T, Nagasaki N, Abuduwaili M, Hata K, Hiyama Y, Oka S, Yoshihara M, Kitadai Y, Tanaka S, Chayama K.

J Gastroenterol Hepatol. 2019 May 7. doi: 10.1111/jgh.14706. [Epub ahead of print]

PMID:
31062875
25.

Effects of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin on Blood Pressure in Hypertensive Patients with Type 2 Diabetes Mellitus.

Kishimoto S, Kinoshita Y, Matsumoto T, Maruhashi T, Kajikawa M, Matsui S, Hashimoto H, Takaeko Y, Kihara Y, Chayama K, Goto C, Mohamad Yusoff F, Nakashima A, Noma K, Higashi Y.

Am J Hypertens. 2019 Jun 11;32(7):695-702. doi: 10.1093/ajh/hpz065.

PMID:
31045223
26.

Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development.

Lupberger J, Croonenborghs T, Roca Suarez AA, Van Renne N, Jühling F, Oudot MA, Virzì A, Bandiera S, Jamey C, Meszaros G, Brumaru D, Mukherji A, Durand SC, Heydmann L, Verrier ER, El Saghire H, Hamdane N, Bartenschlager R, Fereshetian S, Ramberger E, Sinha R, Nabian M, Everaert C, Jovanovic M, Mertins P, Carr SA, Chayama K, Dali-Youcef N, Ricci R, Bardeesy NM, Fujiwara N, Gevaert O, Zeisel MB, Hoshida Y, Pochet N, Baumert TF.

Gastroenterology. 2019 Aug;157(2):537-551.e9. doi: 10.1053/j.gastro.2019.04.003. Epub 2019 Apr 9.

PMID:
30978357
27.

Target of Triglycerides as Residual Risk for Cardiovascular Events in Patients With Coronary Artery Disease - Post Hoc Analysis of the FMD-J Study A.

Kajikawa M, Maruhashi T, Kishimoto S, Matsui S, Hashimoto H, Takaeko Y, Yusoff FM, Kihara Y, Chayama K, Goto C, Noma K, Nakashima A, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y.

Circ J. 2019 Apr 25;83(5):1064-1071. doi: 10.1253/circj.CJ-18-1082. Epub 2019 Mar 26.

28.

Diagnostic Yield of Colon Capsule Endoscopy in Detection of Superficial Colorectal Lesions.

Otani I, Oka S, Tanaka S, Iio S, Tsuboi A, Kunihara S, Hiyama Y, Chayama K.

Digestion. 2019 Mar 27:1-8. doi: 10.1159/000499332. [Epub ahead of print]

PMID:
30917377
29.

Impact of sclerosing dacryoadenitis/sialadenitis on relapse during steroid therapy in patients with type 1 autoimmune pancreatitis.

Ishii Y, Serikawa M, Sasaki T, Fujimoto Y, Yamaguchi A, Ogawa T, Noma B, Okazaki A, Yukutake M, Ishigaki T, Chayama K.

Scand J Gastroenterol. 2019 Feb;54(2):259-264. doi: 10.1080/00365521.2019.1577489. Epub 2019 Mar 27.

PMID:
30915865
30.

A case of primary malignant melanoma of the esophagus with a widely expanded surface area.

Nakamura K, Urabe Y, Oka S, Ito M, Kotachi T, Ninomiya Y, Boda T, Hiyama T, Emi M, Hamai Y, Shiroma N, Tanaka S, Chayama K.

Clin J Gastroenterol. 2019 Mar 18. doi: 10.1007/s12328-019-00961-3. [Epub ahead of print]

PMID:
30887427
31.

Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) Infection.

Tsuge M, Uchida T, Walsh K, Ishida Y, Tateno C, Kumar U, Glenn JS, Koh C, Heller T, Uprichard SL, Dahari H, Chayama K.

Viruses. 2019 Mar 15;11(3). pii: E263. doi: 10.3390/v11030263.

32.

Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infection.

Naganuma A, Chayama K, Notsumata K, Gane E, Foster GR, Wyles D, Kwo P, Crown E, Bhagat A, Mensa FJ, Otani T, Larsen L, Burroughs M, Kumada H.

J Gastroenterol. 2019 Aug;54(8):752-761. doi: 10.1007/s00535-019-01569-7. Epub 2019 Mar 13.

33.

Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis.

Hiramatsu A, Aikata H, Uchikawa S, Ohya K, Kodama K, Nishida Y, Daijo K, Osawa M, Teraoka Y, Honda F, Inagaki Y, Morio K, Morio R, Fujino H, Nakahara T, Murakami E, Yamauchi M, Kawaoka T, Miki D, Tsuge M, Imamura M, Tanaka J, Chayama K.

Hepatol Commun. 2019 Jan 22;3(3):348-355. doi: 10.1002/hep4.1309. eCollection 2019 Mar.

34.

Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan.

Takaguchi K, Toyoda H, Tsutsui A, Suzuki Y, Nakamuta M, Imamura M, Senoh T, Nagano T, Tada T, Tachi Y, Hiraoka A, Michitaka K, Shibata H, Joko K, Okubo H, Tsuji K, Takaki S, Watanabe T, Ogawa C, Chayama K, Kumada T, Kudo M, Kumada H.

J Gastroenterol. 2019 Aug;54(8):742-751. doi: 10.1007/s00535-019-01568-8. Epub 2019 Mar 8.

PMID:
30848363
35.

Relationship between home blood pressure and vascular function in patients receiving antihypertensive drug treatment.

Maruhashi T, Kinoshita Y, Kajikawa M, Kishimoto S, Matsui S, Hashimoto H, Takaeko Y, Aibara Y, Yusoff FM, Hidaka T, Chayama K, Noma K, Nakashima A, Goto C, Takahashi M, Kihara Y, Higashi Y; Hiroshima NOCTURNE Research Group.

Hypertens Res. 2019 Aug;42(8):1175-1185. doi: 10.1038/s41440-019-0240-8. Epub 2019 Mar 7.

PMID:
30846869
36.

Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.

Amioka M, Nakano Y, Ochi H, Onohara Y, Sairaku A, Tokuyama T, Motoda C, Matsumura H, Tomomori S, Hironobe N, Okubo Y, Okamura S, Chayama K, Kihara Y.

PLoS One. 2019 Mar 6;14(3):e0213208. doi: 10.1371/journal.pone.0213208. eCollection 2019.

37.

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.

Hamdane N, Jühling F, Crouchet E, El Saghire H, Thumann C, Oudot MA, Bandiera S, Saviano A, Ponsolles C, Roca Suarez AA, Li S, Fujiwara N, Ono A, Davidson I, Bardeesy N, Schmidl C, Bock C, Schuster C, Lupberger J, Habersetzer F, Doffoël M, Piardi T, Sommacale D, Imamura M, Uchida T, Ohdan H, Aikata H, Chayama K, Boldanova T, Pessaux P, Fuchs BC, Hoshida Y, Zeisel MB, Duong FHT, Baumert TF.

Gastroenterology. 2019 Jun;156(8):2313-2329.e7. doi: 10.1053/j.gastro.2019.02.038. Epub 2019 Mar 2.

38.

Reply: Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity -matched analysis in a single institution.

Nakano R, Ohira M, Kobayashi T, Ide K, Tahara H, Kuroda S, Shimizu S, Kimura T, Nagata Y, Aikata H, Chayama K, Ohdan H.

Surgery. 2019 May;165(5):1054-1057. doi: 10.1016/j.surg.2018.10.022. Epub 2019 Feb 22. No abstract available.

PMID:
30799050
39.

Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric mice.

Tsushima K, Tsuge M, Hiraga N, Uchida T, Murakami E, Makokha GN, Kurihara M, Nomura M, Hiyama Y, Fujino H, Ono A, Nakahara T, Yamauchi M, Abe-Chayama H, Kawaoka T, Miki D, Imamura M, Aikata H, Hayes CN, Chayama K.

J Gastroenterol. 2019 Jul;54(7):650-659. doi: 10.1007/s00535-019-01558-w. Epub 2019 Feb 21.

PMID:
30790056
40.

Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes.

Hirano D, Urabe Y, Tanaka S, Nakamura K, Ninomiya Y, Yuge R, Hayashi R, Oka S, Kitadai Y, Shimamoto F, Arihiro K, Chayama K.

PLoS One. 2019 Feb 20;14(2):e0211477. doi: 10.1371/journal.pone.0211477. eCollection 2019.

41.

Screening for inhibitor of episomal DNA identified dicumarol as a hepatitis B virus inhibitor.

Takeuchi F, Ikeda S, Tsukamoto Y, Iwasawa Y, Qihao C, Otakaki Y, Ryota O, Yao WL, Narita R, Makoto H, Watashi K, Wakita T, Takeuchi K, Chayama K, Kogure A, Kato H, Fujita T.

PLoS One. 2019 Feb 19;14(2):e0212233. doi: 10.1371/journal.pone.0212233. eCollection 2019.

42.

Percutaneous transvenous shunt occlusion for portosystemic encephalopathy due to lenvatinib administration to a patient with hepatocellular carcinoma and portosystemic shunt.

Namba M, Kawaoka T, Aikata H, Kodama K, Uchikawa S, Ohya K, Morio K, Fujino H, Nakahara T, Murakami E, Yamauchi M, Tsuge M, Hiramatsu A, Imamura M, Baba Y, Awai K, Chayama K.

Clin J Gastroenterol. 2019 Aug;12(4):341-346. doi: 10.1007/s12328-019-00938-2. Epub 2019 Jan 31.

PMID:
30706429
43.

The utility of a novel colonoscope with retroflexion for colorectal endoscopic submucosal dissection.

Tanaka H, Oka S, Tanaka S, Inagaki K, Okamoto Y, Matsumoto K, Boda K, Yamashita K, Sumimoto K, Ninomiya Y, Hayashi N, Chayama K.

Endosc Int Open. 2019 Feb;7(2):E130-E137. doi: 10.1055/a-0810-0567. Epub 2019 Jan 17.

44.

Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.

Kodama K, Kawaguchi T, Hyogo H, Nakajima T, Ono M, Seike M, Takahashi H, Nozaki Y, Kawanaka M, Tanaka S, Imajo K, Sumida Y, Kamada Y, Fujii H, Seko Y, Takehara T, Itoh Y, Nakajima A, Masaki N, Torimura T, Saibara T, Karino Y, Chayama K, Tokushige K.

J Gastroenterol Hepatol. 2019 Jan 22. doi: 10.1111/jgh.14608. [Epub ahead of print]

PMID:
30668889
45.

Correction: Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study.

Tatsukawa Y, Tsuge M, Kawakami Y, Hiyama Y, Murakami E, Kurihara M, Nomura M, Tsushima K, Uchida T, Nakahara T, Miki D, Kawaoka T, Abe-Chayama H, Imamura M, Aikata H, Ochi H, Hayes CN, Kawakami H, Chayama K.

Antivir Ther. 2019;23(8):709. doi: 10.3851/IMP3289. No abstract available.

PMID:
30632982
46.

The Clinical Usefulness of the PillCam Progress Indicator for Route Selection in Double Balloon Endoscopy.

Tsuboi A, Oka S, Tanaka S, Iio S, Otani I, Kunihara S, Chayama K.

Intern Med. 2019 May 15;58(10):1375-1381. doi: 10.2169/internalmedicine.2043-18. Epub 2019 Jan 10.

47.

Long-term prognosis after treatment for T1 carcinoma of laterally spreading tumors: a multicenter retrospective study.

Yamashita K, Oka S, Tanaka S, Nagata S, Kuwai T, Furudoi A, Tamura T, Kunihiro M, Okanobu H, Nakadoi K, Kanao H, Higashiyama M, Arihiro K, Kuraoka K, Shimamoto F, Chayama K.

Int J Colorectal Dis. 2019 Mar;34(3):481-490. doi: 10.1007/s00384-018-3203-7. Epub 2019 Jan 3.

PMID:
30607579
48.

HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease.

Fujii H, Imajo K, Yoneda M, Nakahara T, Hyogo H, Takahashi H, Hara T, Tanaka S, Sumida Y, Eguchi Y, Chayama K, Nakajima A, Nishimoto N, Kawada N; Japan Study Group of Nonalcoholic Fatty Liver Disease.

J Gastroenterol Hepatol. 2019 Aug;34(8):1390-1395. doi: 10.1111/jgh.14595. Epub 2019 Feb 3.

PMID:
30600551
49.

Gastric Cancer with Submucosal Invasion after Successful Helicobacter pylori Eradication: A Propensity Score-Matched Analysis of Patients with Annual Patient Endoscopic Survey.

Hata K, Ito M, Boda T, Kotachi T, Kiso M, Masuda K, Kurihara M, Kuroki K, Yorita N, Nagasaki N, Abduwali M, Tanaka S, Chayama K.

Digestion. 2019;99(1):59-65. doi: 10.1159/000494414. Epub 2018 Dec 14.

PMID:
30554223
50.

A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update.

Tateishi R, Uchino K, Fujiwara N, Takehara T, Okanoue T, Seike M, Yoshiji H, Yatsuhashi H, Shimizu M, Torimura T, Moriyama M, Sakaida I, Okada H, Chiba T, Chuma M, Nakao K, Isomoto H, Sasaki Y, Kaneko S, Masaki T, Chayama K, Koike K.

J Gastroenterol. 2019 Apr;54(4):367-376. doi: 10.1007/s00535-018-1532-5. Epub 2018 Nov 29.

Supplemental Content

Loading ...
Support Center